FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy, and can be used for prevention of complications induced by isoniazid. For this purpose, along with introduction of isoniazid, amaranth seed oil is used produced by cold pressing of germs and shells of amaranth seeds in the dose of 600 mg 1 time a day 1 hour prior to the meal before noon daily as per the therapeutic course of 3-4 weeks, at extension of the anti-tuberculosis therapy the said is used as continuous assistance with the interval between courses of 1 month.
EFFECT: invention ensures reduction of severity of metabolic and morphological hepatic disorders in acute disorders induced by isoniazid, reduction of intensity of pathological changes in the cardiovascular system and the central nervous system.
1 cl, 2 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF ISONIAZID-INDUCED HEPATOTOXIC REACTIONS | 2015 |
|
RU2601919C1 |
| MEANS FOR BODY MICROCIRCULATORY PROCESSES IMPROVEMENT AND METHOD FOR ITS APPLICATION | 2015 |
|
RU2646463C2 |
| METHOD FOR REDUCING NEUROTOXICITY CAUSED BY A COMPLEX OF ANTI-TUBERCULOSIS DRUGS IN EXPERIMENT | 2023 |
|
RU2820957C1 |
| METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
| THERAPEUTIC AGENT FOR PREVENTING AND TREATING CHRONIC LIVER DISEASES | 2012 |
|
RU2526172C2 |
| PREPARATION FOR TUBERCULOSIS TREATMENT | 1994 |
|
RU2080114C1 |
| SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
| NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
| TUBERCULOUS AGENT AS SOLUTION FOR INJECTION | 2007 |
|
RU2358742C2 |
| IMMUNOMODULATING DRUG | 1996 |
|
RU2112543C1 |
